Fine Mark National Bank & Trust Abbott Laboratories Transaction History

Fine Mark National Bank & Trust

  • $2.84 Billion
  • Q3 2024

A detailed history of Fine Mark National Bank & Trust transactions in Abbott Laboratories stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 49,550 shares of ABT stock, worth $5.74 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
49,550
Previous 52,791 6.14%
Holding current value
$5.74 Million
Previous $5.49 Million 2.99%
% of portfolio
0.2%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$100.07 - $118.13 $324,326 - $382,859
-3,241 Reduced 6.14%
49,550 $5.65 Million
Q2 2024

Aug 02, 2024
SELL
$100.73 - $112.44 $156,232 - $174,394
-1,551 Reduced 2.85%
52,791 $5.49 Million
Q1 2024

May 14, 2024
BUY
$109.52 - $120.96 $191,660 - $211,680
1,750 Added 3.33%
54,342 $6.18 Million
Q4 2023

Feb 09, 2024
BUY
$90.19 - $110.4 $77,383 - $94,723
858 Added 1.66%
52,592 $5.79 Million
Q3 2023

Nov 15, 2023
SELL
$95.53 - $114.62 $140,142 - $168,147
-1,467 Reduced 2.76%
51,734 $5.01 Million
Q2 2023

Aug 11, 2023
BUY
$100.78 - $112.29 $64,700 - $72,090
642 Added 1.22%
53,201 $5.8 Million
Q1 2023

May 08, 2023
BUY
$96.86 - $114.01 $51,529 - $60,653
532 Added 1.02%
52,559 $5.32 Million
Q4 2022

Feb 09, 2023
BUY
$95.06 - $111.52 $6,844 - $8,029
72 Added 0.14%
52,027 $5.71 Million
Q3 2022

Nov 14, 2022
SELL
$96.76 - $112.03 $101,307 - $117,295
-1,047 Reduced 1.98%
51,955 $5.03 Million
Q2 2022

Aug 09, 2022
SELL
$102.07 - $123.37 $93,087 - $112,513
-912 Reduced 1.69%
53,002 $5.76 Million
Q1 2022

May 16, 2022
BUY
$114.02 - $139.04 $37,284 - $45,466
327 Added 0.61%
53,914 $6.38 Million
Q4 2021

Feb 14, 2022
SELL
$115.53 - $141.46 $234,641 - $287,305
-2,031 Reduced 3.65%
53,587 $7.54 Million
Q3 2021

Nov 12, 2021
BUY
$116.66 - $129.06 $62,529 - $69,176
536 Added 0.97%
55,618 $6.57 Million
Q2 2021

Aug 13, 2021
SELL
$105.79 - $124.53 $111,291 - $131,005
-1,052 Reduced 1.87%
55,082 $6.39 Million
Q1 2021

May 12, 2021
BUY
$108.84 - $128.23 $50,392 - $59,370
463 Added 0.83%
56,134 $6.73 Million
Q4 2020

Feb 10, 2021
BUY
$105.0 - $114.42 $158,340 - $172,545
1,508 Added 2.78%
55,671 $6.1 Million
Q3 2020

Nov 12, 2020
BUY
$91.64 - $111.29 $41,329 - $50,191
451 Added 0.84%
54,163 $5.9 Million
Q2 2020

Aug 13, 2020
SELL
$76.57 - $98.0 $21,745 - $27,832
-284 Reduced 0.53%
53,712 $4.91 Million
Q1 2020

May 06, 2020
BUY
$62.82 - $91.86 $89,204 - $130,441
1,420 Added 2.7%
53,996 $4.26 Million
Q4 2019

Feb 07, 2020
SELL
$78.51 - $87.4 $1.22 Million - $1.36 Million
-15,527 Reduced 22.8%
52,576 $4.57 Million
Q3 2019

Nov 08, 2019
BUY
$81.84 - $88.74 $1.49 Million - $1.62 Million
18,255 Added 36.62%
68,103 $5.7 Million
Q2 2019

Aug 08, 2019
BUY
$72.88 - $85.0 $983,952 - $1.15 Million
13,501 Added 37.14%
49,848 $4.19 Million
Q1 2019

May 07, 2019
SELL
$66.22 - $80.06 $266,336 - $322,001
-4,022 Reduced 9.96%
36,347 $2.91 Million
Q4 2018

Feb 07, 2019
BUY
$65.56 - $74.27 $2,425 - $2,747
37 Added 0.09%
40,369 $2.92 Million
Q3 2018

Nov 02, 2018
SELL
$60.81 - $73.36 $3.77 Million - $4.55 Million
-61,974 Reduced 60.58%
40,332 $2.96 Million
Q2 2018

Aug 03, 2018
BUY
$57.57 - $63.54 $183,705 - $202,756
3,191 Added 3.22%
102,306 $6.24 Million
Q1 2018

Apr 26, 2018
BUY
$56.27 - $63.62 $44,847 - $50,705
797 Added 0.81%
99,115 $5.94 Million
Q4 2017

Jan 30, 2018
SELL
$53.68 - $57.47 $234,688 - $251,258
-4,372 Reduced 4.26%
98,318 $5.61 Million
Q3 2017

Oct 30, 2017
BUY
$48.06 - $53.64 $4.94 Million - $5.51 Million
102,690
102,690 $5.48 Million

Others Institutions Holding ABT

# of Institutions
3,187
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Fine Mark National Bank & Trust Portfolio

Follow Fine Mark National Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email